Treatment Information

Back

Prostate Cancer treatment details. Chemotherapy.

University of Siena, Siena, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:3City/State/Province:Siena
Treatments:ChemotherapyHospital:University of Siena
Drugs:Journal:Link
Date:Mar 2015

Description:

Patients:
This study involved 26 advanced, metastatic castration-resistant prostate cancer patients who had been previously treated with docetaxel and abiraterone acetate. The median patient age was 72 years.

Treatment:
Patients received chemotherapy with docetaxel and epirubicin.

Toxicities:
The most severe toxicities were of grade 3 and included neutropenia, anemia, and fatigue.

Results:
The median overall survival was 10.7 months.

Correspondence: Dr. Roberto Petrioli; email: [email protected]



Back